CLINICAL_TRIALS
trial_result
· 2025-05-30
Clinical Trial Update: Targeting Leukotrienes in Kidney Disease [Phase 3]
Summary
A Phase 3 trial investigating leukotriene-targeting therapy for diabetic kidney disease was terminated, with results posted in 2025.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Colorado, Denver | Conditions: Diabetic Kidney Disease | Phase 3 | Status: TERMINATED | Results posted: 2025-05-30